SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Hagen Steven R (Last) (First) (Middle) 21 CORPORATE CIRCLE PO BOX 15098 (Street) ALBANY NY 12212 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 11/03/2008	3. Issuer Name and Ticker or Trading Symbol ALBANY MOLECULAR RESEARCH INC [ AMRI ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP Pharmaceutical Dev & Mfg	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase Common Stock	03/05/2010	03/05/2017	Common Stock	1,800	$9.34	D
Option to purchase Common Stock	03/05/2011	03/05/2017	Common Stock	600	$9.34	D
Option to purchase Common Stock	03/05/2012	03/05/2017	Common Stock	600	$9.34	D
Option to purchase Common Stock	03/17/2011	03/17/2018	Common Stock	4,500	$11.21	D
Option to purchase Common Stock	03/17/2012	03/17/2018	Common Stock	1,500	$11.21	D
Option to purchase Common Stock	03/17/2013	03/17/2018	Common Stock	1,500	$11.21	D

Explanation of Responses:

1. Amount represents 12,000 Restricted Shares granted on November 14, 2005, 2,500 Restricted Shares granted on May 5, 2006, 5,000 Restricted Shares granted on November 10, 2006, 1,000 Restricted Shares granted on March 5, 2007 and 2,500 Restricted Shares granted on March 17, 2008, all pursuant to the Albany Molecular Research, Inc. 1998 Stock Option and Incentive Plan.

	/s/ Mark T. Frost, by power of attorney	11/04/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.